Full Text Journal Articles in
Journal J. Natl. Cancer Inst.

Advertisement

Find full text journal articles






Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors.

Jennifer L Guida, Tim A Ahles, Daniel Belsky, Judith Campisi, Harvey Jay Cohen, James DeGregori, Rebecca Fuldner, Luigi Ferrucci, Lisa Gallicchio, Leonid Gavrilov, Natalia Gavrilova, Paige A Green, Chamelli Jhappan, Ronald Kohanski, Kevin Krull, Jeanne Mandelblatt, Kirsten K Ness, Ann O'Mara, Nathan Price, Jennifer Schrack, Stephanie Studenski, Olga Theou, Russell P Tracy, Arti Hurria,

Observational data have shown that some cancer survivors develop chronic conditions like frailty, sarcopenia, cardiac dysfunction, and mild cognitive impairment earlier and/or at a greater burden than similarly aged individuals never diagnosed with cancer or exposed to systemic or targeted cancer therapies. In aggregate, cancer- and treatment-related physical, cognitive, and ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



The future is prosperous.

Harry J de Koning,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.

William E Barlow, Elisabeth F Beaber, Berta M Geller, Aruna Kamineni, Yingye Zheng, Jennifer S Haas, Chun R Chao, Carolyn M Rutter, Ann G Zauber, Brian L Sprague, Ethan A Halm, Donald L Weaver, Jessica Chubak, V Paul Doria-Rose, Sarah Kobrin, Tracy Onega, Virginia P Quinn, Marilyn M Schapira, Anna N A Tosteson, Douglas A Corley, Celette Sugg Skinner, Mitchell D Schnall, Katrina Armstrong, Cosette M Wheeler, Michael J Silverberg, Bijal A Balasubramanian, Chyke A Doubeni, Dale McLerran, Jasmin A Tiro,

BACKGROUND:Cancer screening is a complex process encompassing risk assessment, the initial screening examination, diagnostic evaluation, and treatment of cancer precursors or early cancers. Metrics that enable comparisons across different screening targets are needed. We present population-based screening metrics for breast, cervical, and colorectal cancers for nine sites participating in the ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



RE: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.

Federica Tomao, Pierluigi Benedetti Panici, Silverio Tomao,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Mammographic Density Change and Risk of Breast Cancer.

Shadi Azam, Mikael Eriksson, Arvid Sjölander, Roxanna Hellgren, Marike Gabrielson, Kamila Czene, Per Hall,

BACKGROUND:We examined the association between annual mammographic density change (MDC) and breast cancer (BC) risk, and how annual MDC influences the association between baseline mammographic density (MD) and BC risk. METHODS:We used the KARMA cohort of Swedish women (N = 43,810) aged 30-79 years with full access to BC risk factors and ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Response to Tomao, Panici, and Tomao.

Janet R Vos, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells.

Man-Li Luo, Jingjing Li, Liping Shen, Junjun Chu, Qiannan Guo, Guorun Liang, Wei Wu, Jianing Chen, Rufu Chen, Erwei Song,

BACKGROUND:Tumor growth can be addicted to vital oncogenes, but whether long non-coding RNAs (lncRNAs) are essential to cancer survival is largely uncharacterized. METHODS:We retrieved GEO datasets to identify lncRNAs overexpression in 257 cancers versus 196 normal tissues and analyzed the association of ST8SIA6-AS1 (termed Aurora A/PLK1 associated lncRNA, APAL) with ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System.

Yvonne L Eaglehouse, Matthew W Georg, Craig D Shriver, Kangmin Zhu,

BACKGROUND:Non-Hispanic Black (NHB) adults with cancer may have longer time-to-treatment than Whites (NHW) in the U.S. Unequal access to medical care may partially account for this racial disparity. This study aimed to investigate whether there were racial differences in time-to-treatment and in treatment delays for patients diagnosed with colon cancer ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Quality of life during palliative systemic therapy for oesophagogastric cancer: systematic review and meta-analysis.

Jessy Joy van Kleef, Emil Ter Veer, Héctor G van den Boorn, Sandor Schokker, Lok Lam Ngai, Mariska J Prins, Nadia Haj Mohammad, Lonneke V van de Poll-Franse, Aeilko H Zwinderman, Martijn G H van Oijen, Mirjam A G Sprangers, Hanneke W M van Laarhoven,

BACKGROUND:Palliative systemic therapy can prolong life and reduce tumour related symptoms for patients with advanced oesophagogastric cancer. However, side effects of treatment could negatively impact health-related quality of life (HRQoL). Our aim was to review the literature and conduct a meta-analysis to examine the effect of palliative systemic therapy on ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Re: Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research and Policy.

Michael Jefford,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program.

Anna M Chiarelli, Kristina M Blackmore, Derek Muradali, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea Eisen, Linda Rabeneck, Ellen Warner,

BACKGROUND:The Ontario Breast Screening Program (OBSP) expanded in July 2011 to screen high risk women aged 30-69 with annual magnetic resonance imaging (MRI) and digital mammography. This study examined the benefits of screening with mammography and MRI by age and risk criteria. METHODS:This prospective cohort study included 8,782 women aged ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Re: Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research and Policy.

Larissa Nekhlyudov, Lawrence N Shulman, Paul B Jacobsen, Michelle A Mollica, Ann M Geiger, Deborah K Mayer,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Breast cancer screening in high-risk women: is MRI alone enough?

Carolina Rossi Saccarelli, Almir G V Bitencourt, Elizabeth A Morris,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Annual versus biennial screening: diagnostic accuracy among concurrent cohorts within the Ontario Breast Screening Program.

Anna M Chiarelli, Kristina M Blackmore, Lucia Mirea, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Linda Rabeneck, Derek Muradali,

BACKGROUND:The Ontario Breast Screening Program (OBSP) recommends annual mammography to women 50-74 at increased risk due to family history of breast or ovarian cancer or personal history of ovarian cancer or mammographic density ≥75%. Few studies have examined diagnostic accuracy of recommendations based on risk factors and included both screen-film ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



A review of perspectives on the use of randomization in phase II oncology trials.

Michael J Grayling, Munyaradzi Dimairo, Adrian P Mander, Thomas F Jaki,

Historically, phase II oncology trials assessed a treatment's efficacy by examining its tumor response rate in a single-arm trial. Then, approximately 25 years ago, certain statistical and pharmacological considerations ignited a debate around whether randomized designs should be utilized instead. Here, based upon an extensive literature review, we review the ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

Paolo Giorgi Rossi, Eugenio Paci,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



In Memoriam: Paul Alphonso Godley, MD, PhD, MPP.

Otis Webb Brawley,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls.

Yukihide Momozawa, Yusuke Iwasaki, Makoto Hirata, Xiaoxi Liu, Yoichiro Kamatani, Atsushi Takahashi, Kokichi Sugano, Teruhiko Yoshida, Yoshinori Murakami, Koichi Matsuda, Hidewaki Nakagawa, Amanda B Spurdle, Michiaki Kubo,

BACKGROUND:Genetic testing has been conducted in patients with prostate cancer (PCa) using multi-gene panels, but no centralized guidelines for genetic testing exist. To overcome this limitation, we investigated the demographic and clinical characteristics of patients with pathogenic variants. METHODS:We sequenced eight genes associated with hereditary PCa in 7,636 unselected Japanese ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Overdiagnosis and lives saved due to reflex testing men with intermediate prostate-specific antigen levels.

Roman Gulati, Todd M Morgan, Teresa A'mar, Sarah P Psutka, Jeffrey J Tosoian, Ruth Etzioni,

BACKGROUND:Several prostate cancer early detection biomarkers are available for reflex testing in men with intermediate prostate-specific antigen (PSA) levels. Studies of these biomarkers typically provide information about diagnostic performance but not about overdiagnosis and lives saved, the primary drivers of associated harm and benefit. METHODS:We projected overdiagnoses and lives saved ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Response to Habel and Buist.

Marc D Ryser, E Shelley Hwang,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Trends in mortality due to cancer in the US by age and county-level income, 1999-2015.

Diana R Withrow, Amy Berrington de González, Susan Spillane, Neal D Freedman, Ana F Best, Yingxi Chen, Meredith S Shiels,

Disparities in cancer mortality by county-level income have increased. It is unclear whether these widening disparities have affected older and younger adults equally. National death certificate data were utilized to ascertain cancer deaths during 1999-2015. Average annual percent changes (AAPCs) in mortality rates and mortality rate ratios (RRs) were estimated ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Response to van Diest, Zweemer, and Piek.

Suzanne C Dixon-Suen, Penelope M Webb, Louise F Wilson, Karen Tuesley, Louise M Stewart, Susan J Jordan,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Re: Cancer outcomes in DCIS patients without locoregional treatment.

Laurel A Habel, Diana S M Buist,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial.

Ma Somsouk, Carly Rachocki, Ajitha Mannalithara, Dianne Garcia, Victoria Laleau, Barbara Grimes, Rachel B Issaka, Ellen Chen, Eric Vittinghoff, Jean A Shapiro, Uri Ladabaum,

BACKGROUND:Colorectal cancer (CRC) screening remains underutilized especially in safety-net systems. The objective of this study was to determine the effectiveness, costs, and cost-effectiveness of organized outreach using fecal immunochemical tests (FIT) compared with usual care. METHODS:Patients aged 50-75 years eligible for CRC screening from eight participating primary care safety-net clinics ... Read more >>

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Re: the Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study.

Paul J van Diest, Ronald P Zweemer, Jurgen M J Piek,

J. Natl. Cancer Inst. (Journal of the National Cancer Institute)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.5719 s